Fatty liver disease: Should you be tested?
Weight-loss drug may lower risk of heart attacks and infections
Testosterone therapy without evidence of deficiency may boost heart risk
Even a little exercise linked with lower stroke risk in people with afib
Antihistamines may not offer meaningful relief from eczema symptoms
What to eat on the DASH diet
Tricep workouts you can do at home
FDA approves first mRNA-based flu vaccine
Migraine: How it's diagnosed and what that means
Mindfulness practices to reduce stress and improve focus
Dhruv Kazi, MD, MSc, MS
Contributor
Dr. Dhruv S. Kazi is a cardiologist and health economist. He is associate professor of medicine at Harvard Medical School, associate professor of epidemiology at the Harvard T.H. Chan School of Public Health, associate director of the Smith Center for Outcomes Research, and director of the cardiac critical care unit at Beth Israel Deaconess Medical Center. He completed clinical training at the University of Mumbai, Baylor College of Medicine, and the University of California, San Diego, with graduate training at the London School of Economics and Stanford. His research evaluates the benefit, affordability, and uptake of high-value cardiovascular and weight management therapies.
Fatty liver disease: Should you be tested?
Weight-loss drug may lower risk of heart attacks and infections
Testosterone therapy without evidence of deficiency may boost heart risk
Even a little exercise linked with lower stroke risk in people with afib
Antihistamines may not offer meaningful relief from eczema symptoms
What to eat on the DASH diet
Tricep workouts you can do at home
FDA approves first mRNA-based flu vaccine
Migraine: How it's diagnosed and what that means
Mindfulness practices to reduce stress and improve focus
